Time, therapy spur recovery from sudden sensorineural hearing loss

A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.

Sudden sensorineural hearing loss, which affects approximately 4,000 Americans each year, is hearing loss of 30 dB or more that develops over a span of several hours to three days. While the spontaneous recovery rate is high (30 to 60 % of patients may experience recovery within two weeks), little is known about the exact cause.

The study’s authors found that of 121 patients who recovered within three months, nearly half (45.5%) showed delayed recovery after ten days of oral corticosteroid therapy, and of that group, over 78 percent fully recovered within one month.

The study also showed that when there was a lesser degree of hearing loss, the chance of a delayed recovery increased. According the study’s authors, this suggests that even if a 10-day course of treatment fails to spur recovery in a patient, there is enough time to pursue alternative treatment (such as intratympanic steroid administration).

Otolaryngology- Head and Neck Surgery is the official scientific journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF). The authors of the study are Sang-Won Yeo, MD; Dong-Hee Lee, MD; Beom-Cho Jun, MD; and Yong-Soo Park, MD. They are associated with the Department of Otolaryngology at the Catholic University of Korea’s College of Medicine in Seoul, Korea.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel drug delivery system aims to prevent hearing loss from cisplatin chemotherapy